These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8821069)

  • 41. Parkinson's Disease Society Brain Bank, London: overview and research.
    Daniel SE; Lees AJ
    J Neural Transm Suppl; 1993; 39():165-72. PubMed ID: 8360656
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concurrent hereditary haemochromatosis and idiopathic Parkinson's disease: a case report series.
    Costello DJ; Walsh SL; Harrington HJ; Walsh CH
    J Neurol Neurosurg Psychiatry; 2004 Apr; 75(4):631-3. PubMed ID: 15026513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A pilot study of the neuropsychology of obsessive-compulsive disorder and Parkinson's disease: basal ganglia disorders.
    Hollander E; Cohen L; Richards M; Mullen L; DeCaria C; Stern Y
    J Neuropsychiatry Clin Neurosci; 1993; 5(1):104-7. PubMed ID: 8428130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional imaging in Parkinson's disease.
    Dagher A
    Semin Neurol; 2001; 21(1):23-32. PubMed ID: 11346022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Parkinson's disease and progressive supranuclear palsy.
    Stein ZL
    Arch Intern Med; 1985 May; 145(5):952. PubMed ID: 3994473
    [No Abstract]   [Full Text] [Related]  

  • 46. PET imaging of the basal ganglia.
    Laihinen A; Halsband U
    J Physiol Paris; 2006 Jun; 99(4-6):406-13. PubMed ID: 16723212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular genetics, basal ganglia disorders, and the clinical neurologist.
    Eldridge R
    Neurol Clin; 1984 Aug; 2(3):581-603. PubMed ID: 6241956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Telemetric electromyography in kinesiological investigations in neurology].
    Fasshauer K
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1982 Jun; 13(2):92-9. PubMed ID: 6811246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recent advances in Parkinson's disease: basic research. Preface.
    Björklund A; Cenci MA
    Prog Brain Res; 2010; 183():ix-x. PubMed ID: 20696311
    [No Abstract]   [Full Text] [Related]  

  • 50. [Parkinson's disease and extrapyramidal syndromes].
    Dress D
    Infirm Fr; 1973 Dec; 150():21-4. PubMed ID: 4493568
    [No Abstract]   [Full Text] [Related]  

  • 51. Single-photon emission computerized tomography (SPECT) in neuropsychiatry: a review.
    Puri BK; Lewis SW
    Behav Neurol; 1992; 5(3):139-47. PubMed ID: 24487738
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Electromyographic study in extrapyramidal motor disorders].
    Fasshauer K
    Fortschr Med; 1981 May; 99(19):740-4. PubMed ID: 6453806
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The Competence Network Parkinson (CNP)].
    Oertel WH; Deuschl G; Eggert K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Apr; 59(4):420-9. PubMed ID: 26961981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Characteristics and dynamics of inpatient treatment of patients with Parkinson's disease in Germany : Analysis of 1.5 million patient cases from 2010 to 2015].
    Tönges L; Bartig D; Muhlack S; Jost W; Gold R; Krogias C
    Nervenarzt; 2019 Feb; 90(2):167-174. PubMed ID: 30083879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiological evaluations of risk factors in Parkinson's disease.
    Kondo K
    Adv Neurol; 1987; 45():289-93. PubMed ID: 3493628
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinical and biochemical aspects of early-onset Parkinson's disease].
    García de Yébenes J; Bazán E; Mena MA; Muradas V; Reiriz J; Romero J; González-Elipe J
    Rev Clin Esp; 1986 Apr; 178(7):343-6. PubMed ID: 3738007
    [No Abstract]   [Full Text] [Related]  

  • 57. Lesions affecting the claustrum.
    Sener RN
    Comput Med Imaging Graph; 1998; 22(1):57-61. PubMed ID: 9745943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interview with Clemens Scherzer--searching for biomarkers in Parkinson's disease.
    Scherzer C
    Biomark Med; 2009 Apr; 3(2):113-4. PubMed ID: 20477503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Clinical aspects and drug therapy of Parkinson's syndrome].
    Mumenthaler M
    Schweiz Med Wochenschr; 1966 Apr; 96(15):479-84. PubMed ID: 4862148
    [No Abstract]   [Full Text] [Related]  

  • 60. Epidemiological clues for the etiology of Parkinson's disease.
    Kondo K
    Adv Neurol; 1984; 40():345-51. PubMed ID: 6695610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.